ethyl 2-((tert-butoxycarbonyl)amino)-4-phenylthiazole-5-carboxylate | 302963-98-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: ethyl 2-((tert-butoxycarbonyl)amino)-4-phenylthiazole-5-carboxylate
• 英文别名: 2-tert-butoxycarbonylamino-4-phenyl-thiazole-5-carboxylic acid ethyl ester；ethyl-2-tert-butoxycarbonyloxyamino-4-phenyl-thiazole-5-carboxylate；Ethyl 2-[(tert-butoxycarbonyl)amino]-4-phenyl-1,3-thiazole-5-carboxylate；ethyl 2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-phenyl-1,3-thiazole-5-carboxylate
• CAS: 302963-98-0
• 化学式: C₁₇H₂₀N₂O₄S
• mdl: MFCD15732435
• 分子量: 348.423
• InChiKey: ZOXQRNFZFFTCSQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  24
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  106
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  ethyl 2-((tert-butoxycarbonyl)amino)-4-phenylthiazole-5-carboxylate 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 生成 2-[[(tert-butyloxy)carbonyl]-amino]-4-phenyl-1,3-thiazole-5-carboxylic acid
  参考文献：
  名称：

  Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56Lck

  摘要：

  A novel series of 2-amino-5-5carboxamidothiazoles were identified as inhibitors of Lck. Structure-activity studies demonstrate the structural requirements for potent Lck activity. Cyclopropylamide 11d is a potent Lck inhibitor having submicromolar activity in a PBL proliferation assay. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.08.054
• 作为产物：
  描述：

  2-氨基-4-苯基-5-噻唑甲酸乙酯 以90.5%的产率得到ethyl 2-((tert-butoxycarbonyl)amino)-4-phenylthiazole-5-carboxylate
  参考文献：
  名称：

  Cyclic protein tyrosine kinase inhibitors

  摘要：

  新型环状化合物及其盐类，含有此类化合物的药物组合物，以及使用此类化合物治疗蛋白质酪氨酸激酶相关疾病，如免疫和肿瘤疾病的方法。

  公开号：

  US20040054186A1

文献信息

• [EN] 2-ACYLAMINOTHIAZOLE DERIVATIVES<br/>[FR] DERIVES DE 2-ACYLAMINOTHIAZOLE
  申请人：LUNDBECK & CO AS H

  公开号：WO2006032273A1

  公开（公告）日：2006-03-30

  The Invention relates to compounds of the formula I, wherein the variables are as defined in the claims, for use as a medicament. The compounds are A2A-receptor legends and are useful in the treatment of neurological and psychiatric disorders where an A2A-receptor is implicated.

  这项发明涉及到公式I的化合物，其中变量如索赔中定义的那样，用作药物。这些化合物是A2A受体的传奇，并在治疗神经系统和精神疾病方面发挥作用，其中A2A受体起到作用。
• 2-acylaminothiazole derivatives
  申请人：H. Lundbeck A/S

  公开号：US07910613B2

  公开（公告）日：2011-03-22

  The Invention relates to compounds of the formula I, wherein the variables are as defined in the claims, for use as a medicament. The compounds are A2A-receptor legends and are useful in the treatment of neurological and psychiatric disorders where an A2A-receptor is implicated.

  本发明涉及公式I的化合物，其中变量如权利要求所定义，用作药物。这些化合物是A2A受体配体，并且在治疗神经和精神障碍中具有用处，其中涉及A2A受体。
• 2-Acylaminothiazole Derivatives
  申请人：Larsen Mogens

  公开号：US20090137642A1

  公开（公告）日：2009-05-28

  The Invention relates to compounds of the formula I, wherein the variables are as defined in the claims, for use as a medicament. The compounds are A 2A -receptor legends and are useful in the treatment of neurological and psychiatric disorders where an A 2A -receptor is implicated.

  该发明涉及公式I的化合物，其中变量如权利要求中所定义，用作药物。这些化合物是A2A受体配体，并可用于治疗神经系统和精神疾病，在其中A2A受体被涉及。
• Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56Lck
  作者：John Wityak、Jagabandhu Das、Robert V. Moquin、Zhongqi Shen、James Lin、Ping Chen、Arthur M. Doweyko、Sidney Pitt、Suhong Pang、Ding Ren Shen、Qiong Fang、Henry F. de Fex、Gary L. Schieven、Steven B. Kanner、Joel C. Barrish

  DOI：10.1016/j.bmcl.2003.08.054

  日期：2003.11

  A novel series of 2-amino-5-5carboxamidothiazoles were identified as inhibitors of Lck. Structure-activity studies demonstrate the structural requirements for potent Lck activity. Cyclopropylamide 11d is a potent Lck inhibitor having submicromolar activity in a PBL proliferation assay. (C) 2003 Elsevier Ltd. All rights reserved.
• 2-ACYLAMINOTHIAZOLE DERIVATIVES
  申请人：H.Lundbeck A/S

  公开号：EP1794157A1

  公开（公告）日：2007-06-13